Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02797574 · ClinicalTrials.gov registry record · NA
Stress Response Pathways in Vitiligo
A NA study, sponsored by NYU Langone Health.
- Completed
- Registry status
- NA
- Development phase
- 24
- Enrollment target
NCT02797574 is a NA study that has completed, run by NYU Langone Health. The registered enrollment target is 24 participants.
The verdict
NCT02797574, a NA study, has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 24 participants
- Enrollment target
Study Summary
The purpose of this study is to investigate stress response pathways in tissues and melanocytes from patients with vitiligo. Investigators are collecting evidence of UPR and stress response activation in tissues and melanocytes from patients with vitiligo. Individuals with vitiligo will have punch biopsies to study stress response UPR activation and NF-κB signaling to test our hypothesis. In order to characterize differences between disease and normal states, a second arm of control individuals (Arm 2) will be recruited.
Interventions
- PROCEDURE Punch Biopsy at a Lesional Site
- PROCEDURE Punch Biopsy at a Non- Lesional site
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2015-10 |
| Est. Completion | 2021-09-22 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02797574
The ClinicalTrials.gov registry entry for NCT02797574 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Punch Biopsy at a Lesional Site is the first listed.
NCT02797574 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02797574 about?
NCT02797574 is a clinical study titled "Stress Response Pathways in Vitiligo". The purpose of this study is to investigate stress response pathways in tissues and melanocytes from patients with vitiligo. Investigators are collecting evidence of UPR and stress response activation in tissues and melanocytes from patients with vitiligo. Individuals with vitiligo will have punch b...
What is the current status of trial NCT02797574?
This trial is currently completed. It is a NA study. The enrollment target is 24 participants. The study started on 2015-10. Estimated completion is 2021-09-22.
What interventions are being tested in trial NCT02797574?
The interventions under investigation include: Punch Biopsy at a Lesional Site (PROCEDURE), Punch Biopsy at a Non- Lesional site (PROCEDURE).
Who is sponsoring clinical trial NCT02797574?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.